Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the ... Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 150,000 insulin-dependent diabetics are using it worldwide. Show more
Jury awards $452M in damages Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced that...
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the Omnipod 5 Automated...
Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at three...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -5.51 | -2.0251396648 | 272.08 | 272.77 | 254.7869 | 645073 | 261.47967405 | CS |
4 | 4.06 | 1.54660774828 | 262.51 | 279.77 | 254.7869 | 560252 | 266.45827797 | CS |
12 | 30.09 | 12.724120433 | 236.48 | 279.77 | 225.37 | 541358 | 252.43331534 | CS |
26 | 70.67 | 36.0745278203 | 195.9 | 279.77 | 173 | 648793 | 222.77611089 | CS |
52 | 51.97 | 24.2171481827 | 214.6 | 279.77 | 160.19 | 754009 | 200.04960312 | CS |
156 | 3.36 | 1.27654724365 | 263.21 | 335.91 | 125.82 | 729189 | 222.92832129 | CS |
260 | 94.44 | 54.8655086272 | 172.13 | 335.91 | 121 | 624473 | 226.24173034 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales